Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-Spy 2 Trial Combining (Z)-Endoxifen With Abemaciclib for Er+/Her2- Breast Cancer
atossa therapeutics和quantum leap healthcare collaborative在I-Spy 2試驗中首次給予Er+/Her2-乳腺癌患者(Z)-Endoxifen和Abemaciclib的聯合劑量
